Coherus Oncology, Inc.
CHRS
$1.20
$0.065.26%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -11.96% | 14.84% | -555.13% | -31,632.44% | -302.24% |
| Total Depreciation and Amortization | -0.63% | -43.03% | -44.88% | -42.61% | -22.08% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -115.71% | -96.81% | 115.57% | 152.21% | 169.66% |
| Change in Net Operating Assets | -1,378.69% | -121.41% | -68.14% | 625.02% | -90.71% |
| Cash from Operations | -214.06% | -24,888.20% | -349.52% | 29.73% | -9.15% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 44.39% | -491.28% | -138.01% | -132.04% | -105.69% |
| Cash from Investing | 44.39% | -491.28% | -138.01% | -132.04% | -105.56% |
| Total Debt Issued | -- | -- | -- | -100.00% | -100.38% |
| Total Debt Repaid | -- | 100.00% | 100.00% | 100.00% | 100.00% |
| Issuance of Common Stock | 25,589.21% | 6,960.53% | 238.47% | -92.05% | -98.34% |
| Repurchase of Common Stock | 59.51% | 94.24% | 89.22% | 90.08% | 90.40% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 987.50% | -99.78% | -99.93% | -99.99% | -100.04% |
| Cash from Financing | 31,008.50% | 132.78% | 104.18% | 99.98% | 99.89% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -73.98% | 42.73% | -849.17% | -847.26% | -189.21% |